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• Twenty-three recent cases of orthotopic liver transplantation 
were individually reviewed in an effort to determine why survival 
had declined from the 50% one-year survival rate of an immedi-
ately precedent series. In the series of 23, only six (26%) 
achieved one-year survival. Faulty case selection, technical 
complications, the use of damaged organs, and complications of 
immunosuppression were the main causes of death~ 'AHention 
was directed to the possible use of preoperative lymphoid 
depletion to improve the effectiveness and safety of immunosup-
pression. 
(Arch Surg 115:815-819, 1980) 
Our total experience with orthotopic li\'er transplanta-
tion up to January 1978 ha" been reported' with a 
minimum potential follow-up. of at least one year for every 
recipient. As these 141 cases were compiled there was a 
slow improYemcnt in the one-year sun'i-val rate, which in 
the la~t 30 patients reached the 50% level. ' 
\Ve report here a subsequent, less encouraging experi-
ence in 23 more consecutiw cases. An analysis of these 
recent patients was undertaken to determine the reasons 
for the recent increase in mortality, and to consider furthel' 
policy changes in case selection and management from 
which to mount renewed efforts.' , 
CASE MATERIAL AND METHODS 
Underlying Liver Disease 
The Table gives information on the, 23 cases. There were 12 
adults and 11 childreFl. Among the adults the most common 
diagnosis was chronic aggressh'c hepatitis (six examples). Two 
patients with sclerosing cholangitis had had prc\'ious operations, 
and one (orthotopic transplant rOT] patient 1-19) had a resIdual· 
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duodenal fistula. There was one example each of protoporphyria, 
secondary biliary cirrhosis from an Qld choledochal cyst, primary 
biliary cirrhosis, and alcoholic cirrhosis. 
Of the five children with biliary atresia, three had undergone 
unsuccessful Kasai procedure. Four children had alpha.-antitryp-
sin deficiency and one had congenital hepatic fibrosis. The final 
pediatric patient was a 15-year-old' girl'(OT 150) whose' duct 
system had been excised five years previously during right hepatic 
lobectomy for trauma. Repeated attempts at duct reconstruction 
had failed. At the time of transplantation, a large unsuspected 
, retrohepatic abscess was found and excised along with the contig-
uous liver remnant. 
Donor Sources 
Donor ages .are given in the Table. All db'nors had suffered acute 
irreversible brain injury, usually from trauma. When the livers 
were obtained from Colorado d'onors, graft remo\'aJ and pre6prva-
tion with chilled lactated Ringer's solution were performed at the 
Colorado General Hospital, Den\'er,in an adjacent operating room. 
Consequently, the cold-ischemic times were short (Table). Organs 
removed elsewhere were prese.!.·ved in Collins' solution for six or 
more hours (Table) since they had to be flown to Denver from 
cities as far away as 1,500 miles. 
ImmunosuppressIon 
In all cases, standard treatment was started on the day of 
operation with azathioprine and prednisone. Eleven of the 
patients were' also given intravenous anti thymocyte globulin. 
Seventeen of the 23 re~ipients had concomitant splenectomy and 
one other had splenectomy 21'2 months after transplantation 
because of persistent leukopenia. The five exceptions were 
patients OT 149, 158, 160, 162, and 163. Splenectomy was omitted 
only when the preoperative WBe count was more than 5,OOO/etl 
mm and when the spleen was small. ' 
Thoracic duct drainage (TDD) as described elsewhere' was 
performed in 21 patients. The lymph depletion was begun on the 
day of operation in 17patients, ten and 18 days before transplan-
tation in two others, and two and four weeks after transplantation 
in the final two. The duration of TDD was sen'n to 80 days. 
All patients received livers from donors who had three or four 
HLA mismatches, There was donor/recipient blood-type compati-
bility in all but case OT 148 in whieh the first graft was B to A. 
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Consecutive Recent Orthotopic. Liver Transplantations (OT) ; . 
. ' ''-' 
Donor! Last Cause of Death, l OT Recipient Ischemia Survival, Bilirubin, Clinical and NO. Diagnosis Age, yr Time, hr, min Days Level, mgldL Autopsy 
141 Ch ronic aggressive hepatitis, 17/31 2,46 355 28 Liver failure Irom chronic rejection and re-
hepatitis B surface antigen current hepatitis 
positive (HBsAg + ) f--
14t Alpha,-antitrYPsin deficiency 3Y,I5 3,42 612 0.8 Alive 
(with hepatoblastoma) f---. 
t I 143 Sclerosing cholangitis 17/31 1,45 386 16 Intraabdominal infection; liverfaHure from I"'· q')'Xd '''JIo>.II "- , vt I;!~ chronic rejection; and (?) cholangitis ! w'O .. '\.--
",.," 
144 Alcoholic cirrhosis (previous 19/39 6,15 563 0.8 Alive 
shunt) 
145 Chronic aggressive hepatitis 15/22 7,18 20 16 Acute liver failure from ischemic graft inju- , 
(previous sh un t) ry; candidiasis f---
146 Primary biliary cirrhosis 21/49 1,23 502 0.8 Alive 
r---
147 Biliary atresia 2Y,15Y,' 7,26 42 3.7 Peritonitis from enteric fistu'la; candidiasis 
_.--
.148 Chronic aggressive hepatitis (a)13/29 1,17 16 34 Acute liver failure from (?) ischemic graft I 
(b)leI29 1,29 injury, 1st graft; Gram-negative septice-
mia, 2nd graft 
-
149 Sclerosing cholangitis 18/38 1,34 80 10.6 Peritonitis and persistent duodenal fistula; I I pneumonitis ~K 
- I 
150 Biliary cirrhosis (secondary to 7/15 2,2 472 0.8 Alive 
L-trauma) 1---. I ; 151 Biliary atresia (previous Kasai 2/5 8,51 . 72 3.3. . Chicken po~; fresh portal thrombosis I procedure) f--D~D " _. 
152 Biliary cirrhosis (secondary.to 1 'h 129 2,5 19 8.3 Peritonitis from enteric fistulas; que:otion· "1' ) I 
choledochocyst) able candidiasis; no autopsy L ... 
- -
f------ -' : 
153 Chronic aggressive hepatitis .16/28 2,30 21 1.8 Acute hemorrhage from esophageal I 
varices' i <>-•• _-
154 Alpha,-antitrypsin deficiency 4/6 8,23 54 11 Liver failure with intrahepatic arterial throm- i ! 
bosis; regional liver infarctions a:1d I , Gram-negative septicemia 
.--_.-
: 
155 Alpha,-antitrypsin deficiency 8/11 1,24 395 0.5 Alive f..--.-
156 Chronic aggressive hepatitis (a) 8/24 7,20 .194 6 Acute liver failure from Ischemic injury, 1st 
, 
'(b) 24 :34 5,23 , graft; arterial thrombosis. 2nd graft, neu-
rologic invalidism 
-
! 
; 
.-....f--
157 Chronic -aggressive hepatitis 19/21 2,10 120 35 Liver fatlure from portal thrombosis and (?) ! 
chronic rejection 
~ 
158 Congenital hepatic fibrosiS 2/2 1,45 21 15.4 Acut~ rejection 
t------
- -
159 Alpha,-antitrypsin deficiencl' 3/9 7,39 56 0.8 Pulmonary emboli 
160 Protoporphyria 9/21 8 26 10:8 Cardiac insufficiency; cafldidlasis ~ r----. 
161 Biliary atresia (previous Kasai 1/2 7.12 28 1.lt (?) Adenovirus hepatitis; Gram-negative 
procedure) I septicemia f--
162 Biliary atresia (previous' Kasai 1/2% 6,26 5 3.4 Respiriltory insufffciency from oversized 
procedure) graft 
-
163 Biliary atresia 1 y,/3 1,23 30 2.6t (7) Adenovirus hepatitis 
.. 
-
*At operation; portal cavernous transformation found. Graft portal vein anastomosed to vena caval which subsequently clotted. 
tLast SGOT values more than 2,000 lUlL. 
816 Arch Surg-Vol 115, July 1980 liver Transplantation-Starzl et al 
-
,. II 
-=11 1U1I.=III",.".._ .... ~ff •• I 1IIlBJJ __ ~I~:aKeKfff!gl ... ,: K~I 
:; .• "''''''''''.''''_'''' ..'''iZ:S'''"_== ...... '''''''====-=--___ '''''' ..... -=-====== ____ === .... _~--- ...... ------ --.-
'1 ~ 
~~~ Oli I 
i-~------------~-------------------------4 
Graft Histopathology 
l... .. _, End-stage chronic reJ'ection; Biopsy (bx.l results at 147 and 17!:t days ! I had shown progressing rejection; no evidence of recurrent hepali-
! I tis B infection 
~~----B-x-re-s-u-lt-s-a-t-1-SS--d-a-yp--an-d--1-y-rK-R-T-d-a-y-p-p-h-o-w-e-d-c-o-nt-in-r-in-g--lo-Kt-------4 
I grade rejection 
r-- Diffuse fatty change and some centril9tlular necrosis; no evidence 
of rejection or sclerosing cholangitis 
1-
No bx 
No ischemic injury in bx results at 14 days. only evidence of biliary 
obstruction; same at autopsy 
Bx results at 30 and 111 days showed cellular rejection; no evidence 
of hepatitis despite being HBsAg + 
,- Diffuse fatty change; multiple small foci of Candida infection 
---,' '--____ (a_l_A_c_u_te_c_e_I_lu_la_r_r_ej_e_c_tio_n_;_(_bl_F_a_t_ty_C_h_a_n_9_e_a_n_d_so __ m_e_c_h_o_le_s_ta_s_is ____ -I .-- in entrilob l  hepatocytes 
L--r _____ c_en_t_ri_lo_b_u_la_r_f_at_ty __ Ch_an __ g_e_; _a_rte_r_io_l_ar_n_a_r_ro_W_i_ng __ fr_O_m_p_a_s_t_re_j_ec_t_io_n ____ -:-1 I Bx result at 33 days showed acute cellular rejection ' 
\:.':' l Herpes group viruses seen by electron microscopy in necrotic tissue and in some of adjacent cells 
~--------------------------------------------~ 
. No bx or autopsy ! ' 
liH' ~f -------------------------------------4 Some atrophy of hepatocytes because of lack of portal blood; no 
I I evidence of rejection 
~1~D -----fn-tr-a-h-ep-a-t-ic-a-r-te-r-ia-f-th-ro-m--b-os-e-s-a-n-d-i-n-fa-rc-t-s-in--b-x-re-s-u-ft-p-a-t-O-9-d-a-ys--~ 
I, \: and at autQPsy; no ellidence of rejection in suNiving liver; (?) pri-
mary thrombosis due to endothelial darriage caused by eight hr is- . 
i \ chemia . 
• ' ,.---------------------------------------------------1 i-- Bx result at six mo showed acute cellular rejection 
~_r------------------------------~------------------~ 
, (al Cholangitis. centrilobular cholestasis and marked centrilobular ! and midzonal fatty change; did not look like Simple ischemic dam-
age i (b) Bx results at 69 and 124 days showed acute and chronic rejec-
tion; respectively. with arterial involvement; at autopsy at 179 days 
there were multiple large areas of old and recent ischemic necro-
sis and atrophy of hepatocytes caused by arterial lesions of 
chronic rejection 
Bx results at 14. 62 and 109 days showed progression from acute 
cellular ~ejection to chronic rejection with narrowing and oblitera-
tion of intrahepatic artery branches and portal vein tributaries; at 
autopsy large areas of hemorrhagic n~crosis from recent main por-
tal vein thrombosis predominated 
~-lg Acute celiular rejection with necrosis of centrilobular and midzonal 
I f--_____ h_e_p_a_to_c_~_e_s ________________________________________ ~ 
Little fat in hepatocytes; mild mononuclear cell infiltration of portal I I r tract , ~i--____________________________________________________ ~ 
!i Fatty change and some cholestasis 
" 
Bx results at 16 'days showed acute cellular rejection; no autopsy tis-
sue available 
I Focal areas of centrilobular and midzonal hemorrhagic necrosis; 
I fatty change, cell cholestasis and moderately dense mononuclear 
cell infiltration of portal tracts 
Multiple focal areas of necrosis; some of these contain large candida 
colonies; nuclear inclusions in the hepatocytes bordering the ne-
crotic foci; by electron microscopy these are found to consist of 
adenovirus particles _r---~--~~~~------------------------g 
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Thrpe of the donors had positive cytotoxic cross matches with the 
recipient sera. The resistance of the liver to hyperacute rejection, 
despite the presence of preformed anti donor antibodi(·s. has been 
described previously.' 
Other Management Practices 
The complicated postoperative care of these patients has been 
thoroughly described,' including the need for frequent postopera-
tive diagnostic studies to rule out all causes other than rejection 
for postoperath'e hepatic malfunction. T-tube or transhepatic 
cholangiography and results of repeated liver biopsies were com-
monly used to guide adjustments in -immunosuppression. 
RESULTS 
Mortality and Survival 
As in the past, the overwhelming mortality was early. 
\ 
Within one month, eight of the 18 patients died, and 
between 30 and 90 days there were six more deaths. Three 
more patients died after 4, 6V2, and almost 12 months. 
A final patient died 386 days after transplantation. Five 
remain alive with present follow-ups of 390 to ·612 days 
(Table). All are presently welL The one-year survival rate 
was six of 23 (26%), of whom one subsequently died. 
Causes of Failure 
Individual cases, are documented in the Table. The 
deaths could be classified as follows: 
Insurmountable Preexisting Problems.-Liver transplanta-
tion was fundamentally difficult in most of the patients. 
However, three of the recipients had such severe preexist-
ing pathologic conditions that in retrospect the attempt at 
transplantation was futile. One (OT 153) had a portal 
thrombosis that precluded normal revascularization of the 
liver. The second (OT 149) had a preexisting duodenal 
fistula that was repaired but that reopened postoperatively 
and·was responsible for fatal intraperitoneal infection. The 
third (OT 152) had so many previous procedures that it was 
almost impossible to remove her diseased liver. Postopera-
tively, she died of infection that was made uncontrollable 
by an enteric 41stula. The deaths were after 21, 90, and 19 
days. 
Intraoperative Calamities.-Three of the patients (OT 145, 
148, and 156) received livers that never functioned proper-
ly. All three donors were thought t1) be satisfactory; two of 
the organs were removed at Color.do General Hospital, 
while the third had been preserved and shipped from Los 
Angeles. Bleeding diathesis, perturbed clotting studies, 
and failure of other liver functions were immediately 
evident. Two (OT 148 and 156) were gi~en second organs. 
One did not function. The other retransplant was a techni-
cal success but the patient already had sustained profound 
neurologic injury. Eventually her second graft failed, and 
at autopsy six months later the hepatic artery was throm-
botic. 
The foregoing clinical assessment of ischemic graft 
injury was not reflected in the histopathology of the 
allografts (Table). Acute rejection undoubtedly occurred 
with the first transplant of patient OT 148. Transplant 
patients OT 145 and 156a both showed changes suggestive 
of bile duct obstruction in spite of the fact that T tubes for 
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transhepatic cholangiograms had provided no evidence for 
this possibility. Patient OT 156a also had cholangitis. 
A fourth patient (OT 160) was profoundly hypotensiye 
when taken to the operating room. A latcr report from a 
blood culture revealed enteric organisms. A technically 
satisfactory transplant was performed. However, the car-
diovascular state of the patient remained so poor that an 
intraaortic balloon support to maintain the blood pressure 
was required for a week. He subsequently died of dissem-
inated candidiasis. A fifth patient (OT 162) who received a 
liver too large to be accommodated in the abdomen died 
five days later of respiratory failure. 
Delayed Technical Cornplications.-One patient each had 
delayed thrombosis of the portal vein (OT 157) and of the 
hepatic artery (OT 154) at some distance from the vascular 
anastomosis. Results of serial biopsies of patient OT 157 
had revealed progression from acute to chronic rejection 
and the eventual portal thrombosis may have been second-
ary to these events (Table). In two patients enteric fistulas 
developed from the Roux-en-Y reconstruction, leading to 
early (OT 147) or late (OT 143) death. 
Acute Viral Infection.-Two patients (OT 161 and 163) had 
almost identical courses after initially satisfactory graft 
function. After almost a month, fulminating liver failure 
developed in both children, with SGOT level rises of 2,000 
to 3,000 IU. They died so quickly that their bilirubin levels 
rose to only 2.6 and 1.1 mg/dL, respectively. Adenovirus 
had been previously grown in cultures taken from the 
throat and rectum of one patient; and in the other, 
adenovirus was grown in cultures taken from the allograft 
at autopsy. The graft of patient OT 161 had contained 
eyiclence of acute cellular rejection at day 16 (Table). At 
autopsy, multiple focal areas of necrosis were seen in case 
OT 163. There were basophilic nuclear inclusions in the 
hepatocytes bordering the necrotic foci, and electron 
microscopy revealed that these inclusions were composed 
of adenm-irus particles. This graft also contained colonies 
of candida Crable). 
In addition, a 5-year-old child (OT 151) who had had an 
untroubled recovery was discharged from the hospital. 
-Systemic chicken pox with pneumonitis and acute liver 
failure then developed, with an !SGOT level of 5,000 IV. At 
autopsy, chicken pox and cytomegalovirus grew from 
cultures taken from the con~iolidated lungs but not from 
the liver allograft. However, herpes group viruses were 
seen by electron microscopy in the necrotic hepatocytes in 
the central and middle zones of the lobules of the liver 
allografl. The portal vein contained a fresh thrombosis 
that was thought to be only one or two days old_ 
_Acute Rejection.-By clinicopathologic correlation, only 
one patient (OT 158) was lost solely because of acute 
uncontrolled rejection of the graft. The histopathologic 
rejection was equally severe in the first graft of patient OT 
148, but this organ hau never functioned, and the failure 
was ascribed by the clinicians to ischemic injury. 
Miscellaneous.-A 9-year-old girl (OT 159) with a seem-
ingly perfect result died 56 days postoperatively of massh-e 
pulmonary emboli that had come from the collateral Ret-
. , . 
ZIllS vems. 
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A 31-year-old man (OT 141) had a Iivertransplantatbn -
for chronic aggressive hepatitis, hepatitis B surface anti-
gen (HBsAg) positive. In spite of postoperative treatment 
of the patient with specific hyperimmune globulin, th.; 
results of his HBsAg tests became positive again after 
several weeks. He died of liver failure 355 days postopera-
tively. The differential diagnosis of rejection vs recurrent 
hepatitis was evaluated from several biopsy specimens and 
from the autopsy allograft. These showed rejection pro-
gressing until only isolated nodules "Of hepatocytes 
remained at autopsy. Investigations with immunoperoxi-
dase and electron microscopy showed no evidence of recur-
rent hepatitis. 
Allograft Histopathology 
Biopsy and autopsy changes for individual cases are 
given in the Table. The autopsy allografts were remark-
ably free of rejection, this being an autopsy diagnosis in 
only five (29%) (OT 141, 149, 156b, 157, 158) of 17 retrieved 
livers. Such findings may have understated the role of 
rejection in lethal clinical events since results of prior 
biopsies confirmed episodes of acute rejection in three 
more allografts (OT 159, 161, 163). Acute rejection at some 
time was found in 12 (52%) (OT 141,142,146, 148a, 149, 150, 
155, 157, 158, 159, 161, 163) of the 23 grafts from which 
tissue was obtained. Chronic rejection, as definl'd by 
intimal thickening and rupture of the internal elastic 
lamina of small intrahepatic arteries, was present in five 
(22%) (OT 141,142,149, 156b. 157) of the 23 grafts. Changes 
suggestive of chronic bile duct obstruction were present in 
three allografts (OT 143, 145, 156a). Viruses were responsi-
ble for widespread liver necrosis in three livers; the 
organism was varicella in one (OT 151) and adenovirus in 
two (OT 161, 163). Candidct abscesses were present in two 
cases (OT 147, 163). Nonspecific fatty change was present 
in six livers (OT 143, 147, 148b, 149, 160 162) mostly in 
association with disseminated bacterial or fungal infec-
tions. The hepatocytes had atrophied in one liver (OT 150) 
- that had been deprived of an adequate portal blood sup-
ply. 
COMMENT 
~e development of liver transplantation has been ham-
pered by the poor condition of almost all recipients, by the 
technical demands of the operation, by lack of effective 
liver support techniques with which to prepare patients for 
operation or to tide them over if initial graft function is 
poor, and by difficulties in defining exactly the reasons for 
postoperative hepatic dysfunction. Nevertheless, a slow 
but steady improvement in survival was reported at our 
institution from 1963 through early 1978' in 141 consecu-
tive cases. The expectation that these gains could be 
maintained was not realized in the 23 subsequent patients 
herein reported. Although the recent sample was a small 
one, we-slowed oUl'liver program almost to a halt in order 
to assess the reasons for the deterioration in results. 
Faulty case selection played a role. Three of the patients 
had such serious anatomical problems that success was 
virtually precluded, and in addition, some of the other 
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patients were so ill and so progressed in the course of their 
liver failure that the final measure of transplantation may 
have been inad\'isable. 
Three otherwise suitable recipients were given poorly 
functioning IiYers. At present, there is no good way to 
identify such flawed organs in ad\·ance. The ischemic 
injury was not clearly related to the time of cold preserva-
tion. Two of the three organs were removed in distant 
cities and shipped to Dem'er with a total cold ischemic 
period of several hours. HO\\'ever, the third graft was 
removed at Colorado General Hospital- and immediately 
transplan ted. 
Similarly, a need to eliminate technical misadventures 
was evident from this recent series as it has been in the 
past; but how to achie\'e this is less definable. The enteric 
and vascular complications occurred at the hands of expe-
rienced surgeons whose record under more favorable cir-
cumstances in patients who did not undergo immunosup-
pressive treatment or in kidney recipients who had 
received immunosuppression has been good. 
With such a spectrum of management problems, it has 
been difficult to assess the additional roles of rejection and 
of the immunosuppressi\'e treatment used to pre\'ent this 
process. Recent publications,' including some from our 
center,' have questioned whether rejection is a major 
factor in the unsatisfactory results and haw drawn atten-
tion to the possible error of o\'erimmunosuppression, espe-
cially with steroids. The occurrence of three deaths from 
acute viral infections of the !i\'er in the present series, as 
well as the high incidence of other infectious complications, 
could be viewed as support for such a contention. 
The issue has not been settled, although there is no douht 
that hepatic allografts at autopsy are usually free of 
histopathologic signs of acute rejection. The liberal use of 
biopsies hag proyided a fuller picture. The biopsy speci-
mens obtained during life often contained evidence of 
rejection to \\'hich the appropriate response at the time was 
increased immunosuppression, Ho\\'eyer, the penalties, 
including the de\-elopment and persistence of enteri<: fistu-
las, ranged from serious to lethal. Thus, the clinician has 
been faced with a situation in which there is little or no 
margin of safety. 
Dissatisfaction with "standard" antirejection therapy 
has prompted us to reevaluate TDD as an adjunct to 
classical immunosuppression, realizing the importance of 
de\'eloping treatment principles with the simpler clinkal 
model of renal transplantation. At first, TDD was insti-
t~lted on the day of renal transplantation, as was done in 
many of the liver recipients of the present series,' It 
became e\'ident that this was a suboptimal use of TDD, 
since renal rejection was common during the first three 
weeks before an immunosuppressive TDD effect was 
established. In the liver recipients herein reported, there 
was no demonstrable benefit from TDD. Although TDD 
was not responsible for the death of any patient, it may 
have contributed to the delayed infectious complications 
while at the same time providing little or no prophylaxis' 
against rejection during the critical first two or three 
postoperative weeks. We now recommend pretreatment 
with TDD for four weeks 01' more, the exact duration being 
strongly influenced by the presence 01' absence of different 
kinds of antibodies in the recipient serum. Using this 
approach, early rejection has been greatly reduced in 
cadaveric kidney recipients.' 
Such an improvement in immunosuppression should be 
applicable to transplantation of other organs, but there 
may be special problems in lh'er recipients. Prospecth'e 
liver recipients are so fragile that a month of TDD 
pretreatment may impose great risks. For one thing, the 
lymph drainage in a patient with hepatic disease tends to 
be voluminous, particularly if ascites is present. In our 
experience, the output may exceed 1 L/hr. Ke\'crtheless, as 
our liver program reopens, we are attempting to prodde 
pretreatment with TDD or with the removal of peripheral 
blood lymphocytes (lymphaphcl'esis). 
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